$343 Million is the total value of Sio Capital Management, LLC's 78 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 45.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MCK | Sell | MCKESSON CORP | $14,925,000 | -16.6% | 97,285 | -26.5% | 4.36% | -27.4% |
| GWPH | Sell | GW PHARMACEUTICALS PLCads | $11,656,000 | -20.8% | 94,984 | -43.5% | 3.40% | -31.0% |
| ANTM | Sell | ANTHEM INC | $8,368,000 | -36.3% | 31,819 | -45.0% | 2.44% | -44.6% |
| UTHR | Sell | UNITED THERAPEUTICS CORP | $7,890,000 | -8.4% | 65,210 | -28.2% | 2.30% | -20.2% |
| BMYRT | Sell | BRISTOL-MYERS SQUIBB COright | $6,155,000 | -27.9% | 1,719,271 | -23.5% | 1.80% | -37.2% |
| VKTX | Sell | VIKING THERAPEUTICS INC | $5,118,000 | +45.4% | 709,780 | -5.6% | 1.49% | +26.6% |
| RDUS | Sell | RADIUS HEALTH INC | $4,940,000 | -1.9% | 362,402 | -6.5% | 1.44% | -14.6% |
| CVM | Sell | CEL-SCI CORPput | $4,937,000 | -67.2% | 330,900 | -74.6% | 1.44% | -71.4% |
| AFMD | Sell | AFFIMED NV | $4,306,000 | +167.6% | 933,150 | -8.4% | 1.26% | +133.2% |
| ARDX | Sell | ARDELYX INC | $4,163,000 | +17.8% | 601,534 | -3.2% | 1.22% | +2.6% |
| QTRX | Sell | QUANTERIX CORP | $3,996,000 | -8.2% | 145,907 | -38.5% | 1.17% | -20.1% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $3,934,000 | -69.5% | 112,036 | -71.7% | 1.15% | -73.5% |
| BIIB | Sell | BIOGEN INC | $3,692,000 | -72.2% | 13,800 | -67.1% | 1.08% | -75.8% |
| IMAB | Sell | I-MABsponsored ads | $3,544,000 | -42.3% | 118,409 | -74.9% | 1.03% | -49.8% |
| ESPR | Sell | ESPERION THERAPEUTICS INC | $3,161,000 | +24.4% | 61,600 | -23.6% | 0.92% | +8.2% |
| SYRS | Sell | SYROS PHARMACEUTICALS INC | $2,909,000 | +4.7% | 272,902 | -41.8% | 0.85% | -8.8% |
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $1,649,000 | -77.9% | 144,114 | -80.0% | 0.48% | -80.8% |
| HROW | Sell | HARROW HEALTH INC | $1,243,000 | +4.5% | 238,623 | -23.4% | 0.36% | -9.0% |
| MORF | Sell | MORPHIC HOLDING INC | $1,228,000 | +68.4% | 45,386 | -8.7% | 0.36% | +46.7% |
| CBIO | Sell | CATALYST BIOSCIENCES INC | $1,166,000 | +22.0% | 198,714 | -9.1% | 0.34% | +6.2% |
| PGNY | Sell | PROGYNY INC | $1,015,000 | +11.2% | 39,310 | -8.8% | 0.30% | -3.3% |
| ARAV | Sell | ARAVIVE INC | $796,000 | +80.5% | 68,373 | -10.6% | 0.23% | +56.8% |
| Sell | TRILLIUM THERAPEUTICS INC | $702,000 | -58.4% | 86,757 | -79.2% | 0.20% | -63.7% | |
| NLTX | Sell | NEOLEUKIN THERAPEUTICS INC | $636,000 | -36.7% | 38,312 | -56.6% | 0.19% | -44.6% |
| BCEL | Sell | ATRECA INC | $458,000 | -41.4% | 21,523 | -54.5% | 0.13% | -48.9% |
| KDMN | Sell | KADMON HOLDINGS INC | $269,000 | -81.0% | 52,500 | -84.4% | 0.08% | -83.3% |
| MEIP | Sell | MEI PHARMA INC | $198,000 | -95.1% | 48,047 | -98.1% | 0.06% | -95.7% |
| Sell | BELLICUM PHARMACEUTICALS INC | $58,000 | 0.0% | 7,751 | -36.8% | 0.02% | -10.5% | |
| MNLO | Exit | MENLO THERAPEUTICS INC | $0 | – | -22,913 | -100.0% | -0.02% | – |
| MIRM | Exit | MIRUM PHARMACEUTICALS INC | $0 | – | -10,701 | -100.0% | -0.05% | – |
| SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -15,395 | -100.0% | -0.05% | – |
| AMRN | Exit | AMARIN CORPORATION PLCspons adr new | $0 | – | -50,000 | -100.0% | -0.07% | – |
| PRVB | Exit | PROVENTION BIO INC | $0 | – | -42,100 | -100.0% | -0.13% | – |
| SUPN | Exit | SUPERNUS PHARMACEUTICALS INC | $0 | – | -25,000 | -100.0% | -0.15% | – |
| IMVTW | Exit | IMMUNOVANT INC*w exp 12/18/2024 | $0 | – | -307,700 | -100.0% | -0.24% | – |
| NXGN | Exit | NEXTGEN HEALTHCARE INC | $0 | – | -90,657 | -100.0% | -0.32% | – |
| VSTM | Exit | VERASTEM INC | $0 | – | -492,085 | -100.0% | -0.44% | – |
| MEDP | Exit | MEDPACE HOLDINGS INC | $0 | – | -20,858 | -100.0% | -0.51% | – |
| HQY | Exit | HEALTHEQUITY INC | $0 | – | -30,700 | -100.0% | -0.52% | – |
| ASND | Exit | ASCENDIS PHARMA A/Ssponsored adr | $0 | – | -13,889 | -100.0% | -0.52% | – |
| ZFGN | Exit | ZAFGEN INC | $0 | – | -2,332,164 | -100.0% | -0.60% | – |
| OSMT | Exit | OSMOTICA PHARMACEUTICALS PLC | $0 | – | -575,000 | -100.0% | -0.61% | – |
| MD | Exit | MEDNAX INC | $0 | – | -176,690 | -100.0% | -0.69% | – |
| ALKS | Exit | ALKERMES PLC | $0 | – | -170,042 | -100.0% | -0.82% | – |
| SYNH | Exit | SYNEOS HEALTH INCcl a | $0 | – | -77,131 | -100.0% | -1.02% | – |
| WBA | Exit | WALGREENS BOOTS ALLIANCE INCcall | $0 | – | -69,400 | -100.0% | -1.06% | – |
| ZBH | Exit | ZIMMER BIOMET HOLDINGS INC | $0 | – | -47,000 | -100.0% | -1.59% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -21,900 | -100.0% | -1.83% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -55,000 | -100.0% | -3.26% | – |
| NVST | Exit | ENVISTA HOLDINGS CORP | $0 | – | -856,922 | -100.0% | -4.29% | – |
| AMGN | Exit | AMGEN INC | $0 | – | -106,069 | -100.0% | -7.21% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| UNITED THERAPEUTICS ORD | 23 | Q3 2023 | 8.3% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 18 | Q3 2023 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
| MCKESSON ORD | 17 | Q1 2022 | 6.0% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
| Brickell Biotech, Inc. | February 14, 2020 | ? | ? |
| Trillium Therapeutics Inc. | February 14, 2020 | 2,751,186 | 9.8% |
| ZAFGEN, INC. | February 14, 2020 | 2,283,164 | 6.1% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2022-11-14 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.